Analyst Price Target is $29.50
▲ +56.33% Upside Potential
This price target is based on 5 analysts offering 12 month price targets for Sutro Biopharma in the last 3 months. The average price target is $29.50, with a high forecast of $37.00 and a low forecast of $22.00. The average price target represents a 56.33% upside from the last price of $18.87.
Current Consensus is
The current consensus among 5 contributing investment analysts is to buy stock in Sutro Biopharma. This Buy consensus rating has held steady for over two years.